MedTrace Logo

Weekly Use of Teriparatide to Accelerate Healing of Distal Radius Fracture

NCT04473989 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2020-07-16

No results posted yet for this study

Summary

The purpose of this study is to examine the effect of weekly dosing strategy on fracture healing.

Conditions

  • Colles' Fracture

Interventions

DRUG

recombinant teriparatide for injection

weekly subcutaneous administration of 40 ug

DRUG

Placebo

weekly subcutaneous administration of 40 ug

Sponsors & Collaborators

  • Peking University Third Hospital

    lead OTHER

Principal Investigators

  • Chunli Song, M.D.; Ph. D. · Peking University Third Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2023-12-01
Completion
2024-06-01

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04473989 on ClinicalTrials.gov